Dr. Lester Crawford, Acting Commissioner of Food and Drug, FDA To Discuss The FDA's Role in Supporting Innovation in the Pharmaceutical Industry During a Keynote at Next Week's 4th Annual World Pharmaceutical Congress.PHILADELPHIA -- Cambridge Healthtech Institute's Fourth Annual World Pharmaceutical Congress will be held May 24-26, 2005 at the Pennsylvania Convention Center The Pennsylvania Convention Center is a multi-use public facility in Philadelphia, Pennsylvania which is designed to accommodate conventions, exhibitions, conferences and other events. in Philadelphia, PA. The World Pharmaceutical Congress (http://www.worldpharmacongress.com/) is the premier R&D event, where pharmaceutical leaders will gather to discuss the industry challenges of bringing new drugs to market with tighter timelines and stricter regulatory scrutiny. The pharmaceutical industry's top R&D leaders will present keynote presentations bringing fresh insight to the scene. Among the confirmed Keynote Speakers are Dr. Lester Crawford Lester Mills Crawford (born March 13, 1938) is a former Commissioner of the United States Food and Drug Administration (FDA). Dr. Crawford resigned from the FDA in September, 2005 - just two months after his approval by the Senate. , Acting Commissioner of Food and Drugs, FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. , Dr. Anthony Ford-Hutchinson, Executive Vice President, Worldwide Basic Research from Merck Research Laboratories, Dr. Abbie Celniker, Senior Vice President for R&D Strategy and Operations, Millennium Pharmaceuticals Millennium Pharmaceuticals NASDAQ: MLNM is a biotechnology company based in the Cambridge, Massachusetts area of the United States of America. Founded in 1993, the company conducts research in various scientific areas, currently focusing on inflammation and oncology. and Willem de Laat, Executive VP, Development and Medical Affairs, Organon International Organon is a pharmaceutical company headquartered in Roseland, New Jersey that is part of Akzo Nobel. Organon deals in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, HRT and anesthesia. Organon sells to international markets. . In addition, Senior Executives from Roche, Wyeth and Pfizer will be panelists on the Plenary Pharmaceutical Executive Panel, Driving Culture to Enhance R&D productivity. The World Pharmaceutical Congress will offer over 100 presentations to choose from and expanded networking opportunities. The in-depth program consists of five comprehensive scientific meetings, an exclusive executive-level forum, pre-conference short course tutorials, plus a closing Partnering Forum. The scientific meetings will cover the topics of Cheminformatics, DMPK DMPK Drug Metabolism and Pharmacokinetics DMPK Dystrophia Myotonica Protein Kinase , High-throughput Screening High-throughput screening (HTS), is a method for scientific experimentation especially used in drug discovery and relevant to the fields of biology and chemistry. Purpose and method , Hit-to-Lead, and Drug Formulation. Presentations will given by leading R&D companies such as AstraZeneca, Bristol-Myers Squibb Bristol-Myers Squibb (NYSE: BMY), colloquially referred to as BMS, is a pharmaceutical corporation, formed by a 1989 merger between pharmaceutical companies Bristol-Myers Company, founded in 1887 by William McLaren Bristol and John Ripley Myers in Clinton, NY (both were , Eli Lilly Eli Lilly can refer to:
The executive forum, R&D Strategies: Managing Risk to Increase Value will address topics such as implementing strategies to improve the quality of validated targets and assessing the value of unmet, untapped markets accurately. Companies developing a promising technology to support drug development and with a strong interest in corporate partnering will participate in the Partnering Forum showcasing cutting-edge technologies in the following areas; DMPK, ADMETox, High-throughput Screening, Drug Formulation, Cheminformatics, Hit-to-Lead, Lead Optimization and Medicinal Chemistry. Participating companies include Ricerca Biosciences Pharmidex, SIDMAP, Jubilant Biosys, ProFACT Proteomics Inc., Biomedical Primate Research Centre The Biomedical Primate Research Centre (BPRC) is Europe's largest primate research centre. It is a scientific research institute that performs research that contributes to the identification and development of new medicines against deadly diseases. , ChemDiv, and VM Discovery. In addition to the Partnering Forum, a showcase of advanced and new technologies will be displayed in the expanded Exhibit Hall, through poster presentations, and at technology workshops. Over 40 exhibitors will demonstrate the latest product and services, poster presenters will share their latest research and discoveries and focused technology workshops will provide opportunity to delve deeper into topics covered in the scientific programming. The World Pharmaceutical Congress will provide a multitude of opportunities to exchange ideas, new tools, and strategies to enhance your R&D productivity. Join you colleagues and contemporaries at the Pharmaceutical R&D event of the year. For further information visit www.WorldPharmaCongress.com About CHI Cambridge Healthtech Institute is dedicated to producing conferences that service the life science community. Our conferences provide valuable new insights and competing points of view on the very latest developments within the pharmaceutical and biomedical bi·o·med·i·cal adj. 1. Of or relating to biomedicine. 2. Of, relating to, or involving biological, medical, and physical sciences. industry. Each year, CHI holds 70 conferences that bring together leaders from their respective discipline. In the past 14 years, CHI has produced over 400 conferences, attracting more than 50,000 attendees from around the world. For more details visit www.healthtech.com For program related inquiries contact: Edel O'Regan at eoregan@healthtech.com To obtain presses pass to this event contact: Lisa Cardinale at lcardinale@healthtech.com For a media partnership contact: Jim MacNeil at jmacneil@healthtech.com |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion